Ratings Administer Oyj

Equities

ADMIN

FI4000513411

Delayed Nasdaq Helsinki Other stock markets 17:00:00 01/07/2024 BST			5-day change	1st Jan Change
2.42 ^EUR	+0.83%		+0.83%	+0.41%

02:16pm	Administer Oyj Boosts Stake in Kuntalaskenta to 90%	MT
04-22	BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

The stock, which is currently worth 2024 to 0.58 times its sales, is clearly overvalued in comparison with peers.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the past year, analysts have significantly revised downwards their profit estimates.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Personal Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ADMINISTER OYJ	+0.41%	37.24M		-
H&R BLOCK, INC.	+13.15%	7.64B		C
ECIT	-4.87%	324M	-	-
COUNT LIMITED	-17.28%	62.45M		-
NEXTPOINT FINANCIAL INC.	-.--%	62.2M	-	-
LICHEN CHINA LIMITED	-24.75%	56.25M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes